Melasma - ميليزما
☆ AI Dermatology — Free Service
2022 ۾ جرمني مان Stiftung Warentest نتيجن، ModelDerm سان صارفين جي اطمينان صرف ادا ڪيل ٽيلي ميڊيسن مشوري جي ڀيٽ ۾ ٿورو گهٽ هئي.
2022 ۾ جرمني مان Stiftung Warentest نتيجن، ModelDerm سان صارفين جي اطمينان صرف ادا ڪيل ٽيلي ميڊيسن مشوري جي ڀيٽ ۾ ٿورو گهٽ هئي.
اها عام حالت آهي جيڪا ايشيائي عورتن ۾ 40 سالن جي شروعات ۾ ظاهر ٿيندي آهي. تصوير ۾ گھميل زخم melasma جي بجاءِ lentigo جي ويجهو آهي.
relevance score : -100.0%
ReferencesTranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. This systematic review searched major databases for relevant publications to March 2016. Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma Area and Severity Index (MASI) showed a decrease of 1.60 in MASI after treat?ment with tranexamic acid. The addition of tranexamic acid to routine treatment modalities resulted in a further decrease in MASI of 0.94. These results support the efficacy and safety of tranexamic acid, either alone or as an adjuvant to routine treatment modalities for melasma.
تازو، low-fluence Q-switched Nd:YAG (LFQSNY) ليزر melasma جي علاج لاء مشهور ٿي چڪو آهي، خاص طور تي ايشيا ۾. متنوع مطالعي کي اختصار ڪرڻ مشڪل هو، پر LFQSNY روايتي علاج جي مقابلي ۾ ميلاسما لاءِ عام طور تي اثرائتو ۽ محفوظ لڳي ٿو. جڏهن ته، ڪجهه ڪيسن ۾ مٽيل hypopigmentation جي رپورٽ ڪئي وئي آهي LFQSNY جي ضمني اثر طور، ممڪن طور تي اعلي ليزر توانائي جي ڪري. LFQSNY جو جارحانه استعمال پڻ سوزش کان هائپر پيگمينٽيشن جو سبب بڻجي سگھي ٿو، خاص طور تي ڳاڙهي چمڙي جي رنگن ۾.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Pigmentation مسئلا اڪثر پرائمري سنڀال ۾ ڏسجن ٿا. عام قسم جي هائپرپيگمينٽيشن ۾ شامل آهن post‑inflammatory hyperpigmentation، melasma، sunspots، freckles، ۽ café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
ميليزما کي ليزر جي علاج سان مڪمل طور تي ختم نٿو ڪري سگهجي، ڇاڪاڻ ته اها هڪ بيماري آهي جنهن ۾ پگمينٽيشن مسلسل پيدا ٿيندي رهندي آهي. Tranexamic acid (ٽرانڪسيمڪ اسڊ) پگمينٽيشن کي گهٽائڻ ۾ مددگار ثابت ٿئي ٿو.
○ علاج
ڪجهه ملڪن ۾ (مثال طور جاپان، ڪوريا) زباني Tranexamic acid (ٽرانڪسيمڪ اسڊ) موجود آهي ۽ اثرائتو ثابت ٿيو آهي. Tranexamic acid ۽ Azelaic acid (ايزيليڪ اسڊ) سان گڏ ميليزما ڪريم جزوي طور مددگار ٿي سگهي ٿو.
Hydroquinone (هائيڊروڪوئنون) عام طور تي هائپر پگمينٽيشن جي علاج لاءِ استعمال ٿيندو هو، پر FDA 2020 تائين Hydroquinone تي مشتمل OTC پروڊڪٽس کي روڪي ڇڏيو.
#Tranexamic acid [TRANSINO]
#Laser toning technique (low fluence QS1064 laser)
#Triluma